New amendment to abortion bill allows exception to protect health of mother
An Indiana House committee made significant changes Tuesday to the Republican-backed bill that would ban virtually all abortions in the state.
An Indiana House committee made significant changes Tuesday to the Republican-backed bill that would ban virtually all abortions in the state.
A startup company that specializes in buying written-off medical accounts is suing a Connecticut insurer for $15.1 million, claiming it failed to fully pay St. Vincent Emergency Physicians for services it provided to its members. Ecure Indiana Corp. filed suit July 28 against United Healthcare Insurance Co.
The clinics are in the crosshairs of the Indiana General Assembly and are likely to face a sharp drop-off in business if current legislation passes that would significantly restrict access to abortion.
The research, published online Tuesday by the journal Science, shows that the Huanan Seafood Wholesale Market was likely the early epicenter of the scourge that has now killed nearly 6.4 million people around the world.
Indiana-based pharmaceutical testing company Inotiv Inc. disclosed late Monday that it expects to incur charges of between $7.4 million and $9.9 million for the previously announced shutdowns of two Virginia animal-breeding facilities.
As the Legislature prepares to convene for a special session to consider abortion-related legislation, some doctors are worried about possible criminal liability they might face for providing abortions, even to save the life of the mother.
The unveiling of the proposal ends weeks of speculation on how restrictive the proposal would be, following the U.S. Supreme Court’s decision to turn such matters over to the states. The Indiana Legislature will convene in special session on Monday to consider the legislation.
Novavax makes a more traditional type of shot than the three other COVID-19 vaccines available for use in the U.S.—and one that’s already available in Europe and multiple other countries.
The surge reversed years of progress fighting one of the gravest public health challenges in modern medicine, according to a new analysis released Tuesday by the Centers for Disease Control and Prevention.
Officials warn of a possible fall or winter wave—perhaps as many as 100 million infections in the United States—that could again flood hospitals with COVID patients.
The FDA is considering ordering a recipe change for the vaccines made by both Pfizer and rival Moderna in hopes that modified boosters could better protect against another COVID surge expected this fall and winter.
The researchers used data from 185 countries to estimate that vaccines prevented 4.2 million COVID-19 deaths in India, 1.9 million in the United States, 1 million in Brazil, 631,000 in France and 507,000 in the United Kingdom.
Paul Peaper starts July 1 as president of the Indiana Health Care Association, which represents more than 485 long-term and post-acute care facilities across the state.
COVID-19 vaccine makers are studying updated boosters that might be offered in the fall to better protect people against future coronavirus surges.
The computer network of Goodman Campbell Brain and Spine, a large, independent surgical group based in Carmel, has been hacked, compromising patient and employee data.
The advance toward a vaccine for infants, toddlers and preschoolers has been an achingly slow and incremental process, with pediatricians and families waiting for an opportunity to vaccinate young children.
Administration officials say they’re running low on money to stock up on, or even begin to order, the latest vaccines, tests and treatments. Also lacking are funds to reimburse doctors treating uninsured patients and to help poor countries control the pandemic.
Despite a nationwide surge in COVID-19 cases, deaths from the virus have remained largely stable over the past eight weeks.
This week, the Centers for Disease Control and Prevention released new estimates of the syndrome’s toll in the United States, suggesting it affects one in five adults younger than 65 who had COVID, and one in four of those aged 65 and older.
There is one more hurdle: The Centers for Disease Control and Prevention must decide whether to formally recommend the booster for this age group. The CDC’s scientific advisers are scheduled to meet on Thursday.